These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 31786618)

  • 1. Pharmacokinetics of methylphenidate and ritalinic acid in plasma correlations with exhaled breath and oral fluid in healthy volunteers.
    Arvidsson M; Dahl ML; Beck O; Ackehed G; Nordin K; Rosenborg S
    Eur J Clin Pharmacol; 2020 Feb; 76(2):229-237. PubMed ID: 31786618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of methylphenidate after oral administration of two modified-release formulations in healthy adults.
    Markowitz JS; Straughn AB; Patrick KS; DeVane CL; Pestreich L; Lee J; Wang Y; Muniz R
    Clin Pharmacokinet; 2003; 42(4):393-401. PubMed ID: 12648029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.
    Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M
    Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of an UFLC-MS/MS method for enantioselectivity determination of d,l-thero-methylphenidate, d,l-thero-ethylphenidate and d,l-thero-ritalinic acid in rat plasma and its application to pharmacokinetic study.
    Zhang C; Luo H; Wu Y; Zhang J; Zhang F; Lin G; Wang H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Feb; 1011():45-52. PubMed ID: 26751592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylphenidate and its isomers: their role in the treatment of attention-deficit hyperactivity disorder using a transdermal delivery system.
    Heal DJ; Pierce DM
    CNS Drugs; 2006; 20(9):713-38. PubMed ID: 16953648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative pharmacodynamics and plasma concentrations of d-threo-methylphenidate hydrochloride after single doses of d-threo-methylphenidate hydrochloride and d,l-threo-methylphenidate hydrochloride in a double-blind, placebo-controlled, crossover laboratory school study in children with attention-deficit/hyperactivity disorder.
    Quinn D; Wigal S; Swanson J; Hirsch S; Ottolini Y; Dariani M; Roffman M; Zeldis J; Cooper T
    J Am Acad Child Adolesc Psychiatry; 2004 Nov; 43(11):1422-9. PubMed ID: 15502602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enantioselective pharmacokinetics of dl-threo-methylphenidate in humans.
    Srinivas NR; Hubbard JW; Korchinski ED; Midha KK
    Pharm Res; 1993 Jan; 10(1):14-21. PubMed ID: 8430051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereoselective urinary pharmacokinetics of dl-threo-methylphenidate and its major metabolite in humans.
    Srinivas NR; Hubbard JW; Korchinski ED; Midha KK
    J Pharm Sci; 1992 Aug; 81(8):747-9. PubMed ID: 1403717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonlinear kinetics of threo-methylphenidate enantiomers in a patient with narcolepsy and in healthy volunteers.
    Aoyama T; Kotaki H; Sasaki T; Sawada Y; Honda Y; Iga T
    Eur J Clin Pharmacol; 1993; 44(1):79-84. PubMed ID: 8436161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma concentrations of methylphenidate enantiomers in adults with ADHD and substance use disorder, with focus on high doses and relationship to carboxylesterase activity.
    Arvidsson M; Franck J; Ackehed G; Pettersson Bergstrand M; Ekström L; Rosenborg S; Dahl ML
    Basic Clin Pharmacol Toxicol; 2022 Apr; 130(4):492-500. PubMed ID: 35040257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of methylphenidate in oral fluid and sweat of a pediatric subject.
    Marchei E; Farrè M; Pellegrini M; García-Algar O; Vall O; Pacifici R; Pichini S
    Forensic Sci Int; 2010 Mar; 196(1-3):59-63. PubMed ID: 20096514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxicokinetic assessment of methylphenidate (Ritalin) in a 13-week oral toxicity study in dogs.
    Bakhtiar R; Ramos L; Tse FL
    Biomed Chromatogr; 2004 Jan; 18(1):45-50. PubMed ID: 14872548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of amphetamine and methylphenidate in exhaled breath of patients undergoing attention-deficit/hyperactivity disorder treatment.
    Beck O; Stephanson N; Sandqvist S; Franck J
    Ther Drug Monit; 2014 Aug; 36(4):528-34. PubMed ID: 24452069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between methylphenidate and ritalinic acid concentrations in oral fluid and plasma.
    Marchei E; Farré M; Pardo R; Garcia-Algar O; Pellegrini M; Pacifici R; Pichini S
    Clin Chem; 2010 Apr; 56(4):585-92. PubMed ID: 20167695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L- and D-threo ethylphenidate concentrations, pharmacokinetics, and pharmacodynamics in horses.
    Knych HK; McKemie DS; Seminoff K; Hartmann P; Hovda L; Benson D
    Drug Test Anal; 2018 Oct; 10(10):1508-1517. PubMed ID: 29786965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enantioselective determination of methylphenidate and ritalinic acid in whole blood from forensic cases using automated solid-phase extraction and liquid chromatography-tandem mass spectrometry.
    Thomsen R; Rasmussen HB; Linnet K;
    J Anal Toxicol; 2012 Oct; 36(8):560-8. PubMed ID: 22833645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-dose pharmacokinetics of methylphenidate extended-release multiple layer beads administered as intact capsule or sprinkles versus methylphenidate immediate-release tablets (Ritalin(®)) in healthy adult volunteers.
    Adjei A; Teuscher NS; Kupper RJ; Chang WW; Greenhill L; Newcorn JH; Connor DF; Wigal S
    J Child Adolesc Psychopharmacol; 2014 Dec; 24(10):570-8. PubMed ID: 25514542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylphenidate bioavailability from two extended-release formulations.
    González MA; Pentikis HS; Anderl N; Benedict MF; DeCory HH; Dirksen SJ; Hatch SJ
    Int J Clin Pharmacol Ther; 2002 Apr; 40(4):175-84. PubMed ID: 11996212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of analytical method for the determination of methylphenidate, the analog ethylphenidate and their metabolite ritalinic acid in oral fluid samples by micro-QuEChERS and liquid chromatography-tandem mass spectrometry.
    Chinaglia KO; Arantes ACF; Cunha KFD; Campos EG; Kahl JMM; Rodrigues LC; Costa JL
    J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Aug; 1205():123330. PubMed ID: 35716546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of ethanol on the pharmacokinetics of methylphenidate's metabolites ritalinic acid and ethylphenidate.
    Koehm M; Kauert GF; Toennes SW
    Arzneimittelforschung; 2010; 60(5):238-44. PubMed ID: 20533759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.